spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Pharma Packaging and Labeling East Coast 2018

21-22 February 2018
Philadelphia, USA

Working together to successfully manage both creative and regulatory demands while safeguarding your products and protecting your patients

The 10th Annual Pharma Packaging and Labeling East Coast event aims to create an environment where commercial packaging and labelingteams work together to successfully manage both creative and regulatory demands while safeguarding products and protecting patients. To achieve this we have brought together top industry leaders whose experience will enable you to make this a reality. 

This year we will be exploring topics which affect both commercial labelling and packaging teams across small, medium and large pharma. We will have a co-presentation looking at the industries end-to-end labeling strategy to ensure companies are inspection readywhile harnessing branding as a storytelling thetool to remain relevant to your consumers, old and new. Coupled with this we aim to show ways through which the operational challenges of serialization can be overcome and improved to ensure you are meeting compliance standards. We are also happy to announce that the Drug Enforcement Administration will be returning, offering an opportunity to hear a different perspective on ways that pharma can serve the public health.

We look forward to welcoming you to Philadelphia on the 21st and 22nd of February 2018 for what is sure to be another year of insightful, interactive and informative panels, roundtables and presentations on issues in commercial packaging and labelling which matter to you!
 
Print this page
Send to a friend
   
spacer
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>


News and Press Releases

Restructure Announcement at Illingworth

As a rapidly growing company, Illingworth Research Group (Illingworth) has reflected on its goals, accomplishments and ambitious future growth plans. This has allowed us to consider opportunities for staff to explore their own growth and development possibilities within a rapidly changing landscape. With that in mind, Illingworth are announcing some significant and exciting changes to our organization. Illingworth remain committed to making patient involvement in clinical trials as stress free as possible and our strengthened management team and launch of our patient concierge service, PatientGO, in combination with global, mobile research nursing will ensure as many patients as possible have the chance to participate in the development of critical drugs, regardless of their geography or socioeconomic class.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement